We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WKL:EURONEXT AMSTERDAMWolters Kluwer N.V. Analysis

Data as of 2026-05-28 - not real-time

€61.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Wolters Kluwer (WKL) is trading at €61.16, comfortably above its 20‑day SMA of €63.52 and well below the 200‑day SMA of €86.69, indicating a long‑term bearish bias. The RSI of 32 suggests the stock is approaching oversold conditions, while the MACD histogram remains negative, confirming short‑term momentum weakness. Technical analysis points to a support zone near €59.33, just above the 52‑week low, and a resistance level at €68.25. Fundamentally, the company generates €6.1 bn in revenue with modest 1.6 % growth, a strong gross margin of 73 % but a very low ROE of 1.1 %, and carries an extreme debt‑to‑equity ratio of 623, which raises balance‑sheet concerns. Despite the leverage, free cash flow of €985 m comfortably covers the €2.52 per‑share dividend, yielding a robust 4.12 % payout and supporting dividend sustainability. Recent material news highlights a new AI‑driven legal workspace release, a strategic executive appointment, and a share‑buyback program, all of which could provide incremental upside if execution aligns with market expectations.
Valuation models place the intrinsic value near €43.6, well below the current price, suggesting the stock is overvalued on a DCF basis, yet its PE of 10.8 is markedly cheaper than the industry average of 30.1, reinforcing a value‑oriented narrative supported by the attractive dividend yield.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (MACD, SMA alignment)
  • Price near immediate support with limited upside
  • High leverage amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield and cash‑flow coverage
  • Value‑oriented valuation relative to peers
  • Ongoing product innovation in AI‑driven legal solutions

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable cash generation supporting dividend sustainability
  • Long‑term value upside if debt is deleveraged
  • Strategic positioning in high‑growth regulatory and AI markets

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin21.36%
P/E Ratio10.8
ROE111.65%
ROA10.01%
Debt/Equity623.06
P/B Ratio17.3
Op. Cash Flow€1.7B
Free Cash Flow€985.5M
Industry P/E30.1

Technical Analysis

TrendBearish
RSI32.1
Support€59.33
Resistance€68.25
MA 20€63.52
MA 50€64.97
MA 200€86.69
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value€43.63
GradeOvervalued
TypeValue
Dividend Yield4.12%

Risk Assessment

Beta0.25
Volatility41.73%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.